A longevity-focused stack pairing GHK-Cu's tissue rejuvenation and antioxidant gene activation with epithalon's proposed telomere-lengthening and pineal gland regulatory effects. GHK-Cu resets gene expression toward a younger phenotype by activating antioxidant and anti-inflammatory gene networks, while epithalon is proposed to slow cellular ageing by stimulating telomerase and regulating circadian and neuroendocrine function. The combination addresses anti-aging at both the cellular replication and tissue maintenance levels.
Mechanism
Resets gene expression toward a more youthful phenotype by activating antioxidant and anti-inflammatory gene networks and stimulating collagen synthesis and tissue matrix remodelling — the primary cellular rejuvenation driver.
Proposed to slow cellular senescence by stimulating telomerase activity and regulating pineal gland function, addressing ageing at the level of cellular replication potential and circadian neuroendocrine balance.
Dual-pathway activation
GHK-Cu × Epithalon
Injectable GHK-Cu is a research compound distinct from topical cosmetic forms with an established skincare safety record. Epithalon is a synthetic tetrapeptide with origins in Soviet-era longevity research; the primary safety and efficacy data comes from Russian studies with limited independent Western replication. Both compounds show low toxicity in available studies, but long-term human safety data is insufficient for either. No formal combination safety data exists.
Research from single Russian institute — no independent Western replication of telomere claims
Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells
A mitochondrial-targeted combination pairing two peptides with distinct but complementary mechanisms. MOTS-c enhances glucose metabolism and AMPK signaling while SS-31 (Elamipretide) stabilizes cardiolipin in the inner mitochondrial membrane, protecting against oxidative damage. Researched in contexts of aging, metabolic dysfunction, and exercise performance.
Both Thymalin and Epithalon are short bioregulatory peptides developed by Vladimir Khavinson and studied across decades of Russian gerontological research. Thymalin is associated with thymic peptide function and immune regulation in aging populations; Epithalon with pineal peptide activity, melatonin normalization, and telomere elongation. The combination is commonly referenced in longevity research for its dual immune-modulating and anti-aging mechanistic rationale.
A synergistic combination of a GHRH analog (Sermorelin) and a ghrelin-mimetic GHRP (GHRP-2) that activates two distinct receptor pathways to amplify natural growth hormone release. Commonly researched for supporting body composition, recovery, and age-related GH decline.
⚠ Educational Use OnlyPeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.
Free newsletter
The Peptide Research Digest
Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.
Prices, providers, and published evidence — tracked independently, never an affiliate code. Get research updates as the data grows.
Free · occasional research updates only · unsubscribe in one click
Already a member? Sign in